| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.0087 | 0.8 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | 0.033 | 0.8 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | -0.0086 | 0.8 |
| mRNA | BIBW2992 | FIMM | pan-cancer | AAC | -0.034 | 0.8 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | 0.0065 | 0.8 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | 0.007 | 0.8 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0076 | 0.8 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | -0.0079 | 0.8 |